Discovery Value Fund Editas Medicine, Inc. Transaction History

Discovery Value Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$14.08 - $27.63 $6.81 Million - $13.4 Million	-483,380 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$39.27 - $72.94 $1.33 Million - $2.47 Million	-33,800 Reduced 6.54%	483,380 $19.9 Million
Q2 2021 Aug 12, 2021	BUY	$31.29 - $56.64 $11 Million - $19.9 Million	351,280 Added 211.74%	517,180 $29.3 Million
Q1 2021 May 13, 2021	BUY	$39.71 - $90.58 $6.59 Million - $15 Million	165,900 New	165,900 $6.97 Million

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $90M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Discovery Value Fund, based on Form 13F filings with the SEC.

Stay updated on Discovery Value Fund with notifications on news.